Shuman S, Golder M, Moss B
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892.
J Biol Chem. 1988 Nov 5;263(31):16401-7.
The putative structural gene encoding the vaccinia virus type I DNA topoisomerase (EC 5.99.1.2) was expressed in Escherichia coli under the control of a bacteriophage T7 promoter. Provision of T7 RNA polymerase resulted in the accumulation to high level of a Mr = 33,000 type I topoisomerase with the properties of the vaccinia enzyme. A simple purification scheme yielded approximately 8 mg of recombinant vaccinia topoisomerase from 400 ml of bacteria. DNA unwinding by the enzyme was stimulated by magnesium, manganese, calcium, cobalt, and spermidine, but inhibited by copper and zinc. Like eukaryotic cellular type I topoisomerases, but unlike the prokaryotic counterpart, the recombinant topoisomerase relaxed positively and negatively supercoiled DNA. The viral topoisomerase I was, however, resistant to the effects of camptothecin, a drug that specifically inhibits cellular type I topoisomerases.
编码牛痘病毒I型DNA拓扑异构酶(EC 5.99.1.2)的假定结构基因在噬菌体T7启动子的控制下于大肠杆菌中表达。提供T7 RNA聚合酶导致积累高水平的具有牛痘酶特性的分子量为33,000的I型拓扑异构酶。一个简单的纯化方案从400毫升细菌中产生了约8毫克重组牛痘拓扑异构酶。该酶的DNA解旋受到镁、锰、钙、钴和亚精胺的刺激,但受到铜和锌的抑制。与真核细胞I型拓扑异构酶一样,但与原核对应物不同,重组拓扑异构酶可使正超螺旋和负超螺旋DNA松弛。然而,病毒拓扑异构酶I对喜树碱的作用具有抗性,喜树碱是一种特异性抑制细胞I型拓扑异构酶的药物。